Replies to post #9586 on Organovo Holdings, Inc. (ONVO)

[WHP03]

Revenue growth is where it's at... if this or any company fails to deliver growth that meets or preferably exceeds guidance they don't deserve an increasing share price. As I said, guidance is $4-6MM. Midyear earnings will be reported in early November. Either they'll meet or exceed expectations or they won't. That will determine where the price goes. If they exceed expectations nothing negative posted on a board like this will mean a thing. If they fail to deliver - nothing positive stated on this board will mean a thing. So we wait. The news has been positive - now it's time to (continue to) show increasing revenue against that news.